SkyAI, Inc.

Company Overview Sharps Technology, Inc. is a medical device sales and distribution enterprise focused on the marketing and distribution of syringe products and related drug-delivery systems. We previously designed and manufactured a portfolio of conventional and safety syringes for clinical, pharmaceutical, and specialty applications and continues to market certain remaining inventory to hospitals, clinics, healthcare providers, and medical supply organizations in both domestic and international markets. We plan to expand its distribution platform by representing established third-party manufacturers of complementary and synergistic medical products serving a common customer base. Sharps Technology is committed to maintaining compliance with all applicable regulatory and quality standards governing the marketing and distribution of medical devices, including those established by the U.S. Food and Drug Administration (FDA) and comparable international authorities. On August 23, 2025, we adopted a digital asset treasury strategy focused on accumulating Solana ( SOL ), the native digital asset of the Solana blockchain. Our Solana Treasury Strategy On August 28, 2025, upon the closing of our Private Investment in Public Equity Offering ( PIPE ) of approximately $400 million, our Board has adopted a treasury policy (the Treasury Policy ), the material terms of which are set forth below, under which the principal holding in our treasury reserve on the balance sheet will be allocated to SOL.